Guidelines for Economic Evaluation of Pharmaceuticals in Korea / 예방의학회지
Journal of Preventive Medicine and Public Health
;
: 80-83, 2008.
Artigo
em Coreano
| WPRIM
| ID: wpr-15552
ABSTRACT
An economic evaluation is required in order to apply to the Health Insurance Review and Assessment Service (HIRA) for a listing in the national drug formulary. To assist companies in preparing the necessary documents, HIRA published guidelines for the economic evaluation of pharmaceuticals in 2006. The guidelines are composed of two parts guidance an explanatory notes. Each guideline reflects the best practice which meets both the theoretical consensus within the academic community and local situations, like data availability. To enhance the transparency of evaluation, guidelines emphasize the reproducibility of data and analysis result. That is, all evaluation processes are required to be described in enough detail to be replicated by reviewers. With growing experience and theoretical development in this area, HIRA guidelines will be revised periodically.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Preparações Farmacêuticas
/
Análise Custo-Benefício
/
Guias como Assunto
/
Farmacoeconomia
/
Coreia (Geográfico)
Tipo de estudo:
Guia de Prática Clínica
/
Avaliação Econômica em Saúde
Limite:
Humanos
País/Região como assunto:
Ásia
Idioma:
Coreano
Revista:
Journal of Preventive Medicine and Public Health
Ano de publicação:
2008
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS